DOXORUBICIN ADJUVANT COMBINATIONS FOR BREAST-CANCER

被引:4
作者
SAUTER, C
机构
关键词
D O I
10.1016/S0140-6736(05)80116-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1550 / 1551
页数:2
相关论文
共 7 条
  • [2] CARPENTER JT, 1991, P ASCO, V10, P45
  • [3] DOXORUBICIN-INDUCED CARDIAC TOXICITY
    DOROSHOW, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) : 843 - 845
  • [4] ETTINGHAUSEN SE, 1986, ARCH SURG-CHICAGO, V121, P1445
  • [5] 2 MONTHS OF DOXORUBICIN-CYCLOPHOSPHAMIDE WITH AND WITHOUT INTERVAL REINDUCTION THERAPY COMPARED WITH 6 MONTHS OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN POSITIVE-NODE BREAST-CANCER PATIENTS WITH TAMOXIFEN-NONRESPONSIVE TUMORS - RESULTS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT B-15
    FISHER, B
    BROWN, AM
    DIMITROV, NV
    POISSON, R
    REDMOND, C
    MARGOLESE, RG
    BOWMAN, D
    WOLMARK, N
    WICKERHAM, DL
    KARDINAL, CG
    SHIBATA, H
    PATERSON, AHG
    SUTHERLAND, CM
    ROBERT, NJ
    AGER, PJ
    LEVY, L
    WOLTER, J
    WOZNIAK, T
    FISHER, ER
    DEUTSCH, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) : 1483 - 1496
  • [6] ADRIAMYCIN CARDIOTOXICITY
    HENDERSON, IC
    FREI, E
    [J]. AMERICAN HEART JOURNAL, 1980, 99 (05) : 671 - 674
  • [7] OBRIAN R, 1992, P AM SOC CLIN ONCOL, V11, P61